I think the Q report due out soon should give us a good idea how sales are going - most likely slow with a gradual ramp up which is normal for product roll outs it takes time to build critical mass in any new product once this wider knowledge of the product is out and about you start to really get going,
All the clinicians will trial a few first and once happy with it they will start selling more.
It cheap time to suck up a few more cheap ones crazy under 3c IMO
ALT Price at posting:
2.6¢ Sentiment: Buy Disclosure: Held
